HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas R Wittenborn Selected Research

Oxi 4503

7/2020Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents.
11/2017The potential of hyperpolarized 13C magnetic resonance spectroscopy to monitor the effect of combretastatin based vascular disrupting agents.
1/2015Targeting tumour hypoxia to improve outcome of stereotactic radiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas R Wittenborn Research Topics

Disease

4Neoplasms (Cancer)
05/2021 - 11/2015
3Carcinoma (Carcinomatosis)
07/2020 - 11/2015
2Hypoxia (Hypoxemia)
11/2017 - 01/2015
1Adenocarcinoma
05/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1Bites and Stings (Sting)
01/2021
1Infections
01/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
11/2015
1Breast Neoplasms (Breast Cancer)
11/2015
1Hyperthermia
01/2015

Drug/Important Bio-Agent (IBA)

3Oxi 4503IBA
07/2020 - 01/2015
1fluoroazomycin arabinosideIBA
05/2021
1pimonidazoleIBA
05/2021
1Oxygen (Dioxygen)IBA
05/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Interferon Type IIBA
01/2021
1InterferonsIBA
01/2021
1VaccinesIBA
01/2021
1CytokinesIBA
01/2021
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2021
1Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
01/2021
1Phosphates (Orthophosphate)IBA
07/2020
1fosbretabulin (combretastatin A4)IBA
07/2020
1Lactic Acid (Lactate)FDA LinkGeneric
11/2017
1Pyruvic Acid (Pyruvate)IBA
11/2017
1Bicarbonates (Hydrogen Carbonate)IBA
11/2017
1Contrast MediaIBA
11/2017
1Biological ProductsIBA
11/2015
1matrigelIBA
11/2015
1Cathepsin LIBA
11/2015
1Dihydrotachysterol (AT 10)IBA
11/2015
1ThiosemicarbazonesIBA
11/2015
1carbogenIBA
01/2015
1NimorazoleIBA
01/2015
1Niacinamide (Nicotinamide)FDA LinkGeneric
01/2015

Therapy/Procedure

1Lasers (Laser)
05/2021
1Therapeutics
07/2020
1Aftercare (After-Treatment)
07/2020
1Radiotherapy
01/2015